An IL-12 DNA vaccine co-expressing Yersinia pestis antigens protects against pneumonic plague (original) (raw)

Profile image of Xinghong YangXinghong Yang

2009, Vaccine

visibility

description

16 pages

link

1 file

Sign up for access to the world's latest research.

checkGet notified about relevant papers

checkSave papers to use in your research

checkJoin the discussion with peers

checkTrack your impact

A parenteral DNA vaccine protects against pneumonic plague

Xinghong Yang

Vaccine, 2010

View PDFchevron_right

Antibodies and cytokines independently protect against pneumonic plague

Jeffrey Adamovicz

Vaccine, 2008

View PDFchevron_right

Vaccines for Mucosal Immunity to Combat Emerging Infectious Diseases

Huan Nguyen

Emerging Infectious Diseases, 2000

View PDFchevron_right

Plague: Past, Present, and Future

Bakyt Atshabar

PLOS Medicine, 2008

View PDFchevron_right

Therapeutic vaccines

James Gulley

Human Vaccines & Immunotherapeutics, 2013

View PDFchevron_right

Vaccines 11 00053 (1)

CELISE DIVINE

View PDFchevron_right

New vaccines needed for pathogens infecting animals and humans

Mirko Zimic

Human Vaccines & Immunotherapeutics, 2012

View PDFchevron_right

Vaccines 10 00186 (2)

Heba M . Attash

View PDFchevron_right

CpG oligodeoxynucleotides augment the murine immune response to the Yersinia pestis F1-V vaccine in bubonic and pneumonic models of plague

Jeffrey Adamovicz

Vaccine, 2009

View PDFchevron_right

Paired Toll-like Receptor Agonists Enhance Vaccine Therapy through Induction of Interleukin-12

Walter Lee

Cancer Research, 2008

View PDFchevron_right

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

DNA vaccines: a rational design against parasitic diseases

Jorge Atouguia

Expert Review of Vaccines, 2010

View PDFchevron_right

Protection in mice passively immunized with serum from cynomolgus macaques and humans vaccinated with recombinant plague vaccine (rF1V)

Jeffrey Adamovicz

Vaccine, 2010

View PDFchevron_right

Mucosal immunity and HIV/AIDS vaccines

Marc GIRARD

Vaccine, 2008

View PDFchevron_right

Challenges of Developing Novel Vaccines With Particular Global Health Importance

Penny Heaton

Frontiers in Immunology, 2020

View PDFchevron_right

Binding of LcrV protein from Yersinia pestis to human T-cells induces apoptosis, which is completely blocked by specific antibodies

Andrey Karlyshev

International Journal of Biological Macromolecules, 2019

View PDFchevron_right

Novel vaccine strategies against emerging viruses

Adolfo García-Sastre

Current Opinion in Virology, 2013

View PDFchevron_right

4th International Workshop in Vaccine Adjuvants and Parasitic Vaccines (Adjuvant 2008)

Oliver Perez

Expert Review of Vaccines, 2008

View PDFchevron_right

Intranasal Administration of an Inactivated Yersinia pestis Vaccine with Interleukin-12 Generates Protective Immunity against Pneumonic Plague

Girish Kirimanjeswara, Devender Kumar

Clinical and Vaccine Immunology, 2011

View PDFchevron_right

Towards a genetic AIDS vaccine

Ben Berkhout

Retrovirology, 2009

View PDFchevron_right

A Nasal Interleukin-12 DNA Vaccine Coexpressing Yersinia pestis F1-V Fusion Protein Confers Protection against Pneumonic Plague

Massimo Maddaloni

Infection and Immunity, 2008

View PDFchevron_right

DNA Vaccines - An Overview

Margaret Liu

Formulation and Delivery in Gene Therapy, DNA Vaccination and Immunotherapy, 2006

View PDFchevron_right

A primer on immune responses and mechanisms

Andrew Kiboneka

Zenodo (CERN European Organization for Nuclear Research), 2023

View PDFchevron_right

Cancer Vaccines and Tumor Immunity

Veronica Preda

2007

View PDFchevron_right

Paving the way towards DNA vaccines

Pierre Meulien

Nature Medicine, 1995

View PDFchevron_right

From Protection to Prevention: Redefining Vaccines in the Context of Antimicrobial Resistance

Johan Snygg

Curēus, 2024

View PDFchevron_right

Vaccines for preventing influenza in healthy adults

Alessandro Rivetti

Reviews, 2010

View PDFchevron_right

Design and Testing for a Nontagged F1-V Fusion Protein as Vaccine Antigen against Bubonic and Pneumonic Plague

Jeffrey Adamovicz

Biotechnology Progress, 2005

View PDFchevron_right

Regulation of the Immune Response

Klaus Bendtzen

Allergy, 1983

View PDFchevron_right

Microevolution and history of the plague bacillus, Yersinia pestis

Thierry Wirth

2004

View PDFchevron_right

Immunepathogenesis, covid-

Dr purva Shoor

View PDFchevron_right

Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine

Jeffrey Adamovicz

Vaccine, 1998

View PDFchevron_right

“Oral Vaccine Antigen Induced Immune Response Signalling Pathways: Current and Future Perspectives”

Anoop kumar

Journal of Vaccines & Vaccination, 2014

View PDFchevron_right

T-Cell Mechanisms against Infectious Disease

Ginta Siahaan

IntechOpen eBooks, 2024

View PDFchevron_right

Stone Age Yersinia pestis genomes shed light on the early evolution, diversity, and ecology of plague

Sergey Vasilyev, Philipp Wolfgang Stockhammer

PNAS, 2022

View PDFchevron_right

Veterinary Parasitic Vaccines - A Current Scenario

V. Rajora

International Journal of Livestock Research, 2013

View PDFchevron_right

MicrobiologyBiologyCytokinesMedicineBiological SciencesCell lineMiceImmunityDNA vaccinesDNA vaccinationImmune systemDNA vaccineFusion ProteinAntigenAdjuvantInterleukinAntibody ResponseMedical and Health Sciences